Strategic COA Growth Modus Outcomes specializes in concept-driven measurement and development of de novo COAs, presenting a sales opportunity to expand into sponsors seeking rigorous patient-centered endpoints for regulatory and promotional claims across high-stakes medical programs.

Clinical Outcome Excellence Position Modus as a Center of Excellence for clinical outcomes assessments, offering end-to-end services from design to validation, which aligns with sponsors needing robust measurement frameworks to de-risk trials and improve CSR and scientific communications.

Multi‑jurisdictional Reach Leverage Modus’s international footprint (US, UK, France) to pursue multinational trials and global submissions, emphasizing capabilities to align regulatory expectations and contextualize COAs across regions.

DCT and Tech Synergy Capitalize on the Thread Research acquisition history and the tech-enabled approach to decentralized trials by offering integrated high-technology and high-science COA solutions, appealing to sponsors pursuing modern, efficient study designs.

Limited but Specialized Scale Target mid to late-stage programs and rare disease initiatives where multi-stakeholder collaboration on PCOMs is valued, highlighting Modus’s expertise in qualitative-quantitative mixed methods and patient-centric concept hierarchies to differentiate from generic providers.